NO Prevention of COVID-19 for Healthcare Providers

• Status: Active, not recruiting
• Trial end date: 2022-04-07
• Target enrollment: 0
• Participant gender: All

Summary

Thousands of healthcare workers have been infected with SARS-CoV-2 and contracted COVID-19 despite their best efforts to prevent contamination. No proven vaccine is available to protect healthcare workers against SARS-CoV-2.

This study will enroll 470 healthcare professionals dedicated to care for patients with proven SARS-CoV-2 infection. Subjects will be randomized either in the observational (control) group or in the inhaled nitric oxide group. All personnel will observe measures on strict precaution in accordance with WHO and the CDC regulations.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Massachusetts General Hospital
• Treatments: Nitric Oxide

Criteria

Inclusion Criteria:

1. Age ≥18 years

2. Scheduled to work with SARS-CoV-2 infected patients for at least 3 days in a week.

Exclusion Criteria:

1. Previous documented SARS-CoV-2 infections and subsequent negative SARS-CoV-2 rt-PCR test.

2. Pregnancy

3. Known hemoglobinopathies.

4. Known anemia